Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe upper arm is one of three licensed injection sites for Mounjaro (tirzepatide), alongside the abdomen and thigh. It works well for most people, though it does take a little more preparation than the other two sites because you cannot easily see or steady the area yourself. Mounjaro is a prescription-only medicine; a prescriber assesses whether it is clinically appropriate before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The correct location is the outer, middle third of the upper arm, roughly halfway between the shoulder tip and the elbow, on the lateral (outer-facing) surface. Avoid the shoulder joint itself, which has bone and little subcutaneous tissue, and avoid the inner arm, where major blood vessels and nerves run closer to the surface.
Subcutaneous injection means placing the medicine into the fatty layer just beneath the skin, not into muscle. Pinching the skin gently between thumb and forefinger before you press the pen in helps lift that layer away from the muscle underneath. If your arm has very little subcutaneous tissue, the abdomen or thigh may be easier sites, worth discussing at your next clinical check-in.
The general guidance on Mounjaro injection sites covers all three locations in detail, but the upper arm is the one that most commonly prompts follow-up questions, mainly because of access and visibility. It is a perfectly valid choice; it just asks for a little more attention to technique than the others.
One quick habit worth building: before every injection, press your fingernail gently against the intended spot and release. If the skin bounces back quickly and you can gather a small fold, there is enough subcutaneous tissue there. That whole check takes under thirty seconds.
Yes, it is possible to self-inject into the upper arm, though it is harder than using the abdomen or thigh because you cannot see the site clearly and stabilising the pen with the same arm you are injecting into takes practice.
A practical approach many people use: rest the back of the upper arm lightly against a wall or doorframe to steady it, then reach across with the other hand to pinch the tissue before pressing the pen in. The KwikPen does not require you to push a plunger manually, you hold it against the skin, press the button, and the pen drives the dose. Keep the pen pressed flat against the skin for the full 10-second count after the click; lifting early can cut the dose short.
If you find the upper arm genuinely awkward, a family member or carer can administer the injection instead, and the technique is identical. There is no clinical reason to force a site that does not work for you. The step-by-step Mounjaro injection guide walks through the full process regardless of which site you choose, and priming the KwikPen correctly is the step that trips people up most often before that.
If you are just starting treatment, our Mounjaro overview has a useful summary of what the first few weeks typically look like.
Some redness, mild swelling or tenderness at the injection site is common, especially in the first weeks of treatment. It usually settles within a day or two without any action needed.
A few things can make site reactions more likely in the upper arm specifically: injecting into the same small patch week after week, using a needle that has already been used, or injecting while the medicine is still cold from the fridge. Letting the pen reach room temperature for around 30 minutes before injecting often reduces discomfort, always follow the exact storage and warming guidance in your Patient Information Leaflet, as the permitted room-temperature window is specified there and should not be exceeded.
Persistent redness that spreads, warmth that does not resolve, hard lumps under the skin (lipohypertrophy), or any signs of infection are reasons to contact a healthcare professional rather than waiting. The page on red or inflamed Mounjaro injection sites covers those scenarios in more detail, including when the reaction warrants medical attention rather than just a change of site. You can also report unexpected side effects via the MHRA Yellow Card scheme, which helps regulators monitor the safety of medicines like Mounjaro in real-world use.
Keeping your arm sites as part of a genuine rotation cycle (abdomen one week, thigh the next, upper arm the next) gives each area time to recover. If you want to compare how the upper arm compares to rotating with the thigh, the Mounjaro thigh injection site page sets out the differences in technique and tissue depth.
According to the NHS guidance on tirzepatide, the three approved sites produce broadly comparable absorption. No site has been shown to deliver meaningfully faster or stronger results than another for most people. The NHS Medicines page on tirzepatide confirms that the abdomen, thigh and upper arm are all suitable and that rotating between them is recommended.
That said, injection into areas affected by lipohypertrophy (thickened, lumpy tissue from repeated injections into the same spot) can reduce absorption unpredictably. That is the main practical reason rotation matters, not just comfort, but consistent delivery of the dose your prescriber has set.
If you are thinking about what Mounjaro costs through a private pharmacy, the Mounjaro price comparison guide explains how private pricing works across providers. And if you have questions specific to the arm as an injection site, our prescribers are the right people to ask, they can review your technique and site preferences as part of your ongoing clinical care. Treatment through nume starts with a free consultation; if clinically suitable, a GPhC-registered prescriber reviews your case the same day.
For a broader look at injection-site choice, this page on arm injection sites for Mounjaro sets out the full context for the upper arm versus other arm-area choices. Ready to talk to a prescriber? Start your free consultation and a clinician will assess whether Mounjaro is right for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.